Understanding how to change one type of cell into another
Decoding the bridges and barriers to cellular reprogramming and lineage identity
This study is exploring how to change one type of cell into another by finding the right genes that can help with this process, which could lead to better treatments for different health conditions in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10693091 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind cellular reprogramming, aiming to discover how to convert one type of cell into another. By identifying specific genes that can trigger this transformation, the study seeks to improve the efficiency of cell type conversion, which is crucial for advancements in regenerative medicine. The researchers will utilize innovative technologies to trace the lineage of individual cells, enhancing our understanding of cell identity and the factors that influence it. This work could lead to breakthroughs in treating various conditions by enabling the generation of specific cell types needed for therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from cell replacement therapies, such as degenerative diseases or injuries.
Not a fit: Patients with stable, non-degenerative conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance regenerative medicine by providing new methods to generate specific cell types for treatment.
How similar studies have performed: Other research has shown promising results in cellular reprogramming, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Raj, Arjun — University of Pennsylvania
- Study coordinator: Raj, Arjun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.